Clinical Trial Update: Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating clozapine augmented with atomoxetine versus clozapine augmented with placebo in chronic resistant schizophrenia; the study status is te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Atomoxetine (Atomoxetine)
• Clozapine (Clozapine)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Schizophrenia | Phase 3 | Status: TERMINATED